
Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

Topics include: Primary Mitochondrial Myopathy Overview; Novel Approaches for Achieving a Diagnosis In Mitochondrial Disease Patients; Patient Diagnostic Journey, Case Study – TK2d, and TK2d Patient Burden of the Disease; Current Treatments - from Patient Perspective, Symptom Management; Multidisciplinary Management
CourseBy Mito Med 2025 Speakers

ICU Management with Acidosis Focus; Update on Stroke Management in the Mitochondrial Disease Patient; Seizing Control: Managing Seizures in Mitochondrial Disease; Case Studies - MELAS/POLG; Navigating Catastrophic Mitochondrial Complications: An Interactive Feedback Session
CourseBy Mito Med 2025 Speakers

Step Toward Treatment of Mito Cardiomyopathy; mtDNA Gene Editing; mtDNA & Deaminases
CourseBy Mito Med 2023 Course 6 Speakers

Mitonuclear Signaling; PINK1- and Parkin-mediated Mitophagy & links to Inflammation & Neurodegeneration; Extracellular ATP Signaling, Inflammation, & Mitochondrial Dysfunction; Are Patients with Mitochondrial Diseases Hypermetabolic?
CourseBy Mito Med 2023 Course 1 Speakers

Vesicular Transfer; Nanotube Transfer; Mito Transfer & Leigh Syndrome; Mito Transplantation; mtFASII Pathway & Mouse Model; Mito FASII in OXPHOS; Small Molecule Therapy
CourseBy Mito Med 2023 Course 7 Speakers

Mitochondrion and Immune System; Viral Exposures in Mito; Mito Dysfunction and COVID-19; Post-Acute Sequelae of COVID-19; Coronaviruses; Flaviviruses; Mito Disease & Viral Exposure; Connections Between Viral Exposome & Mito
CourseBy Mito Med 2023 Course 3 Speakers

Mito & Cellular Metabolism; mtDNA Conformation Regulation; MNRR1 Bicompartmental Mito Regulation; MAT (Mito Augmentation Therapy and MEPAN;
CourseBy Mito Med 2023 Course 4 Speakers

Mito-DNA Encoded Microproteins; mtDNA Transcription Factor Binding; Stem Cells, Organoids & Imaging; mtDNA Haplogroup Disease Associations
CourseBy Mito Med 2023 Course 2 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids
CourseBy Mito Med 2024 Speakers

Topics include: Mitochondrial Diabetes in the University of Chicago Monogenic Diabetes Registry; In Vivo Assessment of Diabetes in Primary Mitochondrial; Mitochondrial Regulation of Thermogenic Fat Activation; Mitochondrial Retrograde Signaling in Metabolic Tissues
CourseBy Mito Med 2025 Speakers